SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001214659-19-004750
Filing Date
2019-07-25
Accepted
2019-07-25 16:30:14
Documents
1
Period of Report
2019-07-23

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT marketforms-45362.html 4  
1 PRIMARY DOCUMENT marketforms-45362.xml 4 4494
  Complete submission text file 0001214659-19-004750.txt   5894
Mailing Address C/O DEXCOM, INC. 5555 OBERLIN DRIVE SAN DIEGO CA 92121
Business Address
Brister Mark (Reporting) CIK: 0001323223 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37897 | Film No.: 19974765

Mailing Address 5421 AVENIDA ENCINAS SUITE F San Diego CA 92008
Business Address 5421 AVENIDA ENCINAS SUITE F San Diego CA 92008 858-480-2400
OBALON THERAPEUTICS INC (Issuer) CIK: 0001427570 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3841 Surgical & Medical Instruments & Apparatus